| 1 |
34504562 | Tofacitinib protects intestinal epithelial cells against oxygen-glucose deprivation/reoxygenation injury by inhibiting the JAK/STAT3 signaling pathway. | 2021 Oct |
1 |
| 2 |
32615452 | Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitis. | 2020 Sep |
1 |
| 3 |
29454012 | Immunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats - Comparison of juvenile and adult responses. | 2018 Apr |
1 |
| 4 |
27708194 | Effects of the Janus Kinase Inhibitor, Tofacitinib, on Testicular Leydig Cell Hyperplasia and Adenoma in Rats, and on Prolactin Signaling in Cultured Primary Rat Leydig Cells. | 2017 Jan |
1 |
| 5 |
28461107 | Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats. | 2017 Nov |
1 |
| 6 |
20701804 | Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis. | 2010 Aug 11 |
4 |
| 7 |
18234077 | Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis. | 2008 |
3 |
| 8 |
17081232 | Janus kinase 3 inhibition with CP-690,550 prevents allograft vasculopathy. | 2006 Dec |
2 |